Email not displaying properly? View email in your browser
logo
Newsletter Vol.44
October 2026
Advertise With Us Get Published Join Our Advisory Board Editorial calendar  
 
banner image
 
Latest EDITION
» Pharma Innovation Breakthroughs
» Functional Excipients in Treatment
» Optimizing ADCs for Cancer
» Biopharma Cleaning & Disinfection
SUBSCRIBE
Pharma Focus Europe Magazine - Latest Edition
 

Articles

AI in Pharma: How Artificial Intelligence Is Reshaping the Industry

Pharmaceutical companies are moving from digital transformation towards decision intelligence. This article examines how AI, analytics and connected platforms...

 

INTERVIEW

Early-Phase Oncology: Advancing Cancer Research

As precision medicine and targeted therapies continue to transform oncology, early-phase trials have become essential in advancing innovative cancer treatments from discovery...

 

NEWS

Catalent and Mantra™ Sign Commercial Supply Deal for Oral Gel Portfolio

Catalent, Inc., the leading global contract development and manufacturing organization (CDMO) dedicated to helping people live better and healthier lives.and Mantra™...

 

PROJECTS

Accelerating Innovation in Cancer Clinical Trials

Evonik has announced a US$100 million investment to modernize its Tippecanoe Labs manufacturing site in Lafayette, Indiana, over the next five years. The investment...

 

PRESS RELEASE

BMS Reports Positive Phase 3 RYZ101 Results in GEP-NETs

Bristol Myers Squibb announced positive topline results from the planned interim analysis of the ACTION-1 trial (NCT05477576) conducted by RayzeBio, Inc.a Bristol...

LATEST APPOINTMENTS

 
Ann Gallo

Anne C. Whitaker

Alkermes Appoints Anne C. Whitaker to Board of Directors

 

Stefan Doboczky

HOVIONE Appoints Stefan Doboczky as Chief Executive Officer

 

Robert Plenge

BioMarin Appoints Robert Plenge, M.D., Ph.D., to Board of Directors

 
Other Appointments →

TECHNO TRENDS

Olomorasib Breakthrough: Lilly Advances Pancreatic Cancer Treatment

Eli Lilly and Company has secured Breakthrough Therapy designation from the US Food and Drug Administration (FDA) for olomorasib, an investigational medicine being developed...

 

RESEARCH INSIGHTS

Predicting Liposome Drug Release with Explainable AI

Liposome formulations have been shown to have varying levels of in vitro release (IVR) under different experimental conditions (formulation characteristics, e.g., lipid...

 

TESTIMONIALS

 

Publishing my article with Pharma Focus Europe was an excellent experience from start to finish. The editorial team was highly professional, responsive, and genuinely invested in ensuring the content met both scientific rigor and industry relevance. Their structured review process, clear communication, and attention to detail made the entire journey seamless. What stands out most is the publication’s ability to connect complex pharmacovigilance and regulatory topics with a broad, decision-making audience across Europe and beyond. It’s a trusted platform for thought leadership, and I’m grateful for the opportunity to contribute. I look forward to collaborating again

Andreas Hofmann,

Managing Director, p.AI GmbH

EVENTS

 
Events Image
Post your Event
Drug Formulation & Drug Delivery 2026
October 21 -23, 2026 | France
 
World Orphan Drug Congress
October 26 – 28, 2026 | Netherlands
 
Pharma Forum EMEA 2026
November 02 - 04, 2026 | Portugal
www.pharmafocuseurope.com
Facebook LinkedIn X